Thursday, October 17
0730-1500
SIU Live Surgery 
Congress Location Athens: Ballroom II-III
Live Surgeries: Istanbul Medipol University, Istanbul, Turkey and Asklepios Klinikum Harburg, Hamburg, Germany
Operating Room Coordinators Istanbul: Mustafa Boz, Turkey; Rahim Horuz, Turkey; Pilar Laguna, Turkey
Panel Coordinators Athens: Anastasios Anastasiadis, Greece; Joyce Baard, The Netherlands; Ranan Dasgupta, United Kingdom
0730 – 0930
SESSION 1 Oncology-Robotics
Moderators: Rafael Coelho, Brazil, Tarik Esen, Turkey, Koon Rha, South Korea, John Varkarakis, Greece, Nianzeng Xing, China
Surgeries:
MRI-US Fusion Biopsies - Baris Bakir, Turkey
Robotic Radical Prostatectomy - Derya Balbay, Turkey
Transperineal Radical Prostatectomy - Selami Albayrak, Turkey
IRE Focal Therapy - Luca Lunelli, France
0930 – 1130
SESSION 2 Reconstructive Surgery
Moderators: Andre Cavalcanti, Brazil, Justin Chee, Australia, Oktay Demirkesen, Turkey, Margit Fisch, Germany
Surgeries:
Posterior Urethroplasty - Anthony Mundy, United Kingdom/Pankaj Joshi, India
Bulbar Urethroplasty - Anthony Mundy, United Kingdom /Stella Ivaz, United Kingdom
Penile Prosthesis - David Ralph, United Kingdom
1130 – 1330
SESSION 3 Endourology Upper Tract
Moderators: Vitor Cavadas, Portugal, Vineet Gauhar, Singapore, Ravindra Sabnis, India; İsmet Yavaşcaoğlu, Turkey
Surgeries:
SMP PCNL - Wenqi Wu, China
UTUC - Michael Grasso, United States
fURS - Alexey Martov, Russia
Mini PCNL - Andreas Skolarikos, Greece
1330 – 1500
SESSION 4 Endourology Lower Tract
Moderators:
Rolf Muschter, Germany, Ahmet Müslümanoğlu, Turkey, Seiji Naito, Japan, Teng Aik Ong, Malaysia, Liping Xie, China
Surgeries:
HoLEP - Lütfi Tunc, Turkey
BiTUEP - Lukas Lusuardi, Austria
Live from Hamburg:
Aquablation - Thorsten Bach, Germany
Objectives:
- Learn about emerging procedures in the area of robotics in oncology
- Apply practical tips and tricks to surgical techniques for robotic oncological procedures such as MRI-fusion biopsies, robotic radical prostatectomy, transperineal radical prostatectomy and IRE focal therapy
- Recognize important considerations in the surgical techniques for reconstructive surgery such as posterior urethroplasty, bulbar urethroplasty and penile prosthesis
- Select the best reconstructive approach for complex cases
- Demonstrate practical knowledge related to the techniques in instrumentation for upper and lower urinary tract cases via surgical and emerging minimally invasive approaches
This session is supported by:
SIU Corporate Sponsors: Coloplast and Karl Storz
Congress Contributors: AngioDynamics, IPG, Lumenis, Minitech and Procept BioRobotics.
1600-1645
SIU@U Studio Session
Roundtable Discussion—Erectile Dysfunction: A Cultural Dialogue
Location: SIU@U Studio, Exhibit Hall
Chair: Koenraad Van Renterghem, Belgium
*Space is limited. Pre-registration is required. Click here to register.*
Faculty:
Sebastien Beley, France
Tariq Hakky, United States
Andrew Kramer, United States
Jay Simhan, United States
Objectives:
- Define the role of culture in the identification and diagnosis of ED
- Recognize cultural and psychosocial barriers related to ED
- Discuss the importance of a sensitive, yet comprehensive approach to the identification and diagnosis of ED
- Practice strategies to overcome cultural barriers through open dialogue and education
- Apply this knowledge to the education and care of patients with ED
- Contribute to the improvement of treatment outcomes and the quality of life of ED patients around the world
This session is supported by SIU Corporate Sponsor Coloplast
Friday, October 18
0830-1130
MRI Master Class: Based on the Cambridge Prostate MRI and Biopsy Course
Location: Theta-Sigma-Delta
Chair: Christof Kastner, United Kingdom
Location: Theta-Sigma-Delta
Faculty: Tristan Barrett, United Kingdom
Description:
The quality and advantages of Prostate MRI have re-defined diagnostic practice in recent years. Recent publications of Hansen BJUi papers, PROMIS and PRECISION the strongly advocate the use of mpMRI for lesion detection and biopsy avoidance in the diagnostic pathway.
This established international workshop has traditionally addressed the approach to learning this new diagnostic tool on workstations in a multidisciplinary fashion involving Radiologists, Urologists and Pathologists.
Original Cambridge course has been delivered annually since 2013 with unanimous applause as a combined MRI & biopsy course. Components have been used successfully for numerous 1-day courses and seminars at the ECR2017, 2018 and 2019, the FT2015, 2018 and 2019 and the SIU 2017 & 2018 and each year since 2013 in Cambridge as the original 2-day course.
0830-0835
Welcome and Introduction of Cambridge Course and Philosophy
0835-0850
Introduction to Prostate Cancer Diagnostics and the Role of MRI
0850-0910
Prostate MRI and PI-RADS
0910-0955
MRI Case Analysis
0955-1010
Abnormal Prostate MRI: Pearl and Pitfalls of Reading and Reporting
1010-1025
To Biopsy or not to Biopsy: Clinical Application of Prostate MRI
1025-1035
Continued Learning and Introduction to MRIpro
1035-1130
MRI Case Analysis
This session is supported by Philips.
0900-1030
Plenary 01
Location: Ballroom II-III
Honorary Chairs: Christopher Evans, United States
Rajeev Kumar, India
Simon Tanguay, Canada
Location: Ballroom II-III
0900-0905
Welcome and SIU Academy Award
0905-0920
Hellenic Urological Association Lecture: Clinical Practice Guidelines: The Unmet Needs
Dionysios Mitropoulos, Greece
0920-0925
Introduction to SIU-Dr. Mostafa Elhilali Award Lecture
0925-0940
SIU-Mostafa Elhilali Award Lecture: Active Surveillance for Early Stage Prostate Cancer - The Future or
the Past?
Peter Carroll, United States
0940-0955
American Urological Association Lecture: The Role of Surgery in Advanced Prostate Cancer
Kelly Stratton, United States
0955-1005
The Future of Regenerative Medicine
Gopal Badlani, United States
1005-1020
Precision Medicine, Christopher Evans, United States
At the end of this lecture, participants will be able to:
-
Understand precision medicine in the context of individual and cohorts of genomic similarities
-
Appreciate genomic alterations in localized and advanced prostate cancer
-
Appreciate how publicly available genomic databases can be useful in research
-
Correlate genomic testing in solid tissue and liquid biopsies
1020-1030
Discussion
This session is supported by an unrestricted educational grant from Takeda Pharmaceutical Company Ltd.
1200-1600
SIU Innovators MRI-TRUS Fusion Hands-On Course
Location: Theta-Sigma-Delta
Chair: Peter Black, Canada
Faculty:
Marc Dall'Era, United States
Boris Hadaschik, Germany
Robert Reiter, United States
Christof Kastner, United Kingdom
1200-1215
Case-based Review of the Basics of MRI Interpretation
Robert Reiter, United States
1215-1220
Q&A
1220-1235
Clinical Results of MRI-TRUS Fusion
Boris Hadaschik, Germany
1235-1240
Q&A
1240-1255
Implementation of MRI-TRUS Fusion in Practice
Marc Dall’Era, United States
1255-1300
Q&A
1300-1325
Introduction to Demo Systems
Christof Kastner, United Kingdom
- Performance Characteristics of Different Systems
1325-1545
Hands-on Session
1545-1600
Wrap-up and Questions and Answers
This session is supported by BK Medical, Eigen, Exact Imaging, Koelis and Philips.
1230-1400
Luncheon Symposium
Optimizing Survival in Metastatic Prostate Cancer
Location: Aphrodite I-II
Chair: Gero Kramer, Austria
Location: Aphrodite I-II
Faculty: Amit Bahl, United Kingdom
Robert van Soest, The Netherlands
1230-1235
Introduction
Gero Kramer, Austria
1235-1300
Understanding Prostate Cancer Biology to Refine Treatment Decisions
Robert van Soest, The Netherlands
1300-1325
Metastatic Prostate Cancer in 2019: Learnings from Randomized Clinical Trials
Gero Kramer, Austria
1325-1350
Managing Metastatic Prostate Cancer in Older Men in Daily Practice
Amit Bahl, United Kingdom
1350-1400
Discussion and Closing Remarks
Gero Kramer, Austria
Objectives:
- To better understand prostate cancer biology to guide treatment choices in metastatic prostate cancer
- To discuss key learnings from randomized clinical trials in metastatic prostate cancer
- To discuss how to manage older patients with metastatic prostate cancer in real life practice
- To discuss the importance of a multidisciplinary approach between urologists, oncologists and radiation oncologists to optimize patient outcomes.
Session description:
Within the last few years, the management of metastatic prostate cancer has dramatically evolved.
Four different classes of therapies have shown an improvement in overall survival including taxanes (docetaxel, cabazitaxel), novel androgen receptor (AR)-targeted agents (abiraterone, apalutamide enzalutamide), immunotherapy (sipuleucel-T) and a bone-targeted radiopharmaceutical (radium-223).1
The rising concern of cross-resistance between novel AR-targeted agents, the evidence that patients may not respond to all available drugs – reflecting the heterogeneity of the disease – and the recent early use of either docetaxel or novel AR-targeted agents combined with androgen deprivation therapy (ADT) for the treatment of newly diagnosed metastatic hormone-sensitive prostate cancer, has increased the complexity of managing patients with metastatic prostate cancer.1-8
The challenge for physicians is to integrate this broad armamentarium rationally in daily practice and appropriately tailor therapy to optimize treatment outcomes and benefits of each individual patient.
References:
- EAU guidelines on prostate cancer (2019 update) – www.uroweb.org
- Attard G et al. J Clin Oncol. 2018;36(25):2639-2646
- Sweeney C et al. N Engl J Med 2015; 373 (8):737-746
- James ND et al. Lancet. 2016;387(10024):1163-77
- Fizazi K et al. N Engl J Med. 2017;. 377(4):352-360
- James ND et al. N Engl J Med. 2017;377(4):338-351
- Chi KN et al. N Engl J Med. 2019;381(1):13-24
- Davies ID et al. N Engl J Med. 2019;381(2):121-131
This session is supported by SIU Corporate Sponsor Sanofi
1300-1400
SIU@U Studio Session
Resident uChallenge: Residents’ Rapid-Fire Q&A
Location: SIU@U Studio, Exhibit Hall
Host: Dean Elterman, Canada
Judge: Kevin Zorn, Canada
For the fourth consecutive year of the SIU@U uChallenge, four urology residents will compete in an exciting 3-round rapid-fire Q&A competition.
We invite all attendees to come cheer on our brave contestants who will compete in a friendly atmosphere for a chance to win the coveted "2019 uChallenge Champion" title along with free registration to the 40th Congress of the SIU, next year in Montreal, Canada.
Will Pratikkumar Shah, our SIU 2018 winner, keep his title?
Join us in Athens on October 18 at 1300 EEST (UTC +3) at the SIU@U Studio located in the Exhibit Hall, or login to SIU@U and watch the game on-demand to find out who the winner is!
This activity is made possible by an unrestricted educational grant provided by SIU Corporate Sponsor, F. Hoffmann-La Roche Ltd.
1730-1755
SIU@U Studio Session
uTalks - Clinical Experience with High Resolution 29MHz Micro-Ultrasound
Location: SIU@U Studio – Exhibit Hall
Faculty: Dr. Laurence Klotz, Canada
Objectives
• Review the potential advantages of high resolution micro-ultrasound compared to conventional ultrasound
• Review the features of significant cancer as they appear on micro-ultrasound
• Review recent data comparing sensitivity of mpMRI and micro-ultrasound, and discuss the limitations of the database.
• Review data on practical aspects of microultrasound, including the learning curve and performance of targeted biopsies.
This session is supported by Exact Imaging
Saturday, October 19, 2019
0800-1530
5th SIU Global Nurses' Educational Symposium
Location: VIP Lounge
Chair: Kay Talbot, Australia
Co-Chair: Amparo Camacho, United States
0800-0805
Welcome
Kay Talbot
Moderators
Vashti Livingston, United States
Kay Talbot
0805-0845
All about BPH
Jaspreet S. Sandhu, United States
Living with Urinary Symptoms—Strategies to Improve Continence
Amparo Camacho
0845-0945
The Transgender Setting – Urological Challenges for the Patient
Sharon Fillingham, United Kingdom
Maurice Garcia, United States
0945-1045
Let’s Not Reinvent the Wheel - How to Adopt Existing Evidence-Based Guidelines Internationally with Nurse's Panel
Dionysios Mitropoulos, Greece
Panelists
Amparo Camacho
Sharon Fillingham
David Heath, Australia
Vashti Livingston, United States
1045-1100
Morning Tea Break (in room) & Viewing of ePosters
1100-1155
Abstract Presentations
Moderators: Kay Talbot
Amparo Camacho
Moderated ePosters
1100–1105
The Application of ERAS Protocol in the Treatment of Patients Under Robot Assisted Laparoscopic Prostatectomy
Ding Yan, China
1105–1110
Effect of Warm Bladder Irrigation Fluid for Benign Prostatic Hyperplasia Patients on Perioperative Hypothermia, Blood Loss and Shiver: A Meta-Analysis
Ding Yan, China
1110–1115
Homeflow: Comfort of Uroflowmetry At Home with Children - A Feasibility Study
Gunter De Win, Belgium
ABSTRACT PRESENTATIONS/ORAL
1115–1125
Decision-Making Style and Influencing Factors of Patients with Prostatectomy
Ding Yan, China
1125–1135
Understanding of Prognosis in Non-metastatic Prostate Cancer: A Randomised Comparative
Study of Clinician Estimates Measured Against the PREDICT Prostate Prognostic Model
Kelly Leonard, United Kingdom
1135–1145
Improving Outpatient Clinical Care Efficiency for Urethral Stricture Patients Using the Home UFlow Meter™
Mariya Dragova, United Kingdom
1145–1155
New Nurse-Innovated Procedure RN Position in Urology Practice
Rena Pinkasova, United States
1155-1215
Counselling Skills for Nurses
Kay Talbot
1215-1230
Q&A
1230-1315
Lunch Break & Viewing of ePosters
Networking lunch provided by Ferring Pharmaceuticals
1315-1355
Developing Roles of the Urology Nurse
David Heath
1355-1430
Medical Tourism – Implications of Apps/Video/Telehealth. Are We Meeting Our Patient’s Needs?
Vashti Livingston
Todd Manning, Australia
1430-1500
Testicular Cancer - Are Young Men Hearing the Message?
Peter Albers, Germany
Kay Talbot
1500-1530
What’s New in Prostate Cancer?
Peter Black, Canada
Arveen Kalapara, Australia
1530
Meeting Close and Save the Date for SIU 2020
Kay Talbot
Amparo Camacho
This session is supported by an unrestricted educational grant by Ferring Pharmaceuticals
0830-1130
MRI Master Class: Based on the Cambridge Prostate MRI and Biopsy Course
Location: Theta-Sigma-Delta
Chair: Christof Kastner, United Kingdom
Faculty: Jurgen Fütterer, The Netherlands
Pre-registration is required for this session.
Session Description:
The quality and advantages of Prostate MRI have re-defined diagnostic practice in recent years. Recent publications of Hansen BJUi papers, PROMIS and PRECISION the strongly advocate the use of mpMRI for lesion detection and biopsy avoidance in the diagnostic pathway.
This established international workshop has traditionally addressed the approach to learning this new diagnostic tool on workstations in a multidisciplinary fashion involving Radiologists, Urologists and Pathologists.
Original Cambridge course has been delivered annually since 2013 with unanimous applause as a combined MRI & biopsy course. Components have been used successfully for numerous 1-day courses and seminars at the ECR2017, 2018 and 2019, the FT2015, 2018 and 2019 and the SIU 2017 & 2018 and each year since 2013 in Cambridge as the original 2-day course.
0830-0835
Welcome and Introduction of Cambridge Course and Philosophy
0835-0850
Introduction to Prostate Cancer Diagnostics and the Role of MRI
0850-0910
Prostate MRI and PI-RADS
0910-0955
MRI Case Analysis
0955-1010
Abnormal Prostate MRI: Pearl and Pitfalls of Reading and Reporting
1010-1025
To Biopsy or not to Biopsy: Clinical Application of Prostate MRI
1025-1035
Continued Learning and Introduction to MRIpro
1035-1130
MRI Case Analysis
This session is supported by Philips
0900-1030
Tips and Tricks in fURS Demo
Location: Lamda/Omega
Chair: Achilles Ploumidis, Greece
Pre-registration is required for this session
.
This session will focus more on EndoUrological procedures (RIRS and PCNL) in terms of
Instrumentation, Technique and Tips and Tricks.
Objectives:
- Learn indications of each technique (PCNL and Retrograde Intra-renal Surgery: RIRS)
- Learn instrumentation for each technique (disposable and reusable equipment)
- Learn basics for manipulation of endoscopes and Laser applications
- Learn principles of management of endourological complications
This session is supported by SIU Corporate Sponsor Coloplast.
1200-1600
SIU Innovators MRI-TRUS Fusion Hands-On Course
Location: Theta-Sigma-Delta
Pre-registration is required for this session.
Chair: Peter Black, Canada
Faculty:
Marc Dall'Era, United States
Boris Hadaschik, Germany
Robert Reiter, United States
Christof Kastner, United Kingdom
1200-1215
Case-based Review of the Basics of MRI Interpretation
Robert Reiter, United States
1215-1220
Q&A
1220-1235
Clinical Results of MRI-TRUS Fusion
Boris Hadaschik, Germany
1235-1240
Q&A
1240-1255
Implementation of MRI-TRUS Fusion in Practice
Marc Dall’Era, United States
1255-1300
Q&A
1300-1325
Introduction to Demo Systems
Christof Kastner, United Kingdom
- Performance Characteristics of Different Systems
1325-1545
Hands-on Session
1545-1600
Wrap-up and Questions and Answers
This session is supported by BK Medical, Eigen, Exact Imaging, Koelis and Philips.
1230-1400
Luncheon Symposium
Current and New Evidence to Manage BPH Patients: When and Why Start 5-ARI + α-Blocker Treatment?
Location: Aphrodite I-II
Chair: Stavros Gravas, Greece
Faculty:
Claus G Roehrborn, United States
Oscar Della Pasqua, United Kingdom
Juan Manuel Palacios, Spain
Description:
There is strong evidence endorsed by clinical guidelines worldwide to support an individualized management of patients with LUTS/BPH. 5-ARI plus α1-blocker combination is a recommended treatment for men with moderate-to-severe LUTS/BPH and an increased risk of disease progression. Despite these guideline recommendations, clinicians still prefer to use α-blockers as first line in such patients. Clinicians are often intrigued with questions about timing on initiation of combination therapy and impact of combination therapy on sexual function.
In this symposium, we aim to provide further insights into these clinical questions and help urologists in the optimal management of patients with moderate to severe BPH at risk of progression. Through engaging clinical cases, this symposium will present and discuss novel and innovative evidence aiming to reconcile clinical guidelines recommendations and clinical practice.
Objectives
• Highlight the existing discordance between guideline recommendations and treatment in clinical practice for men with LUTS/ BPH
• Update the knowledge on new evidence of the impact of combination treatment on sexual function of men with LUTS/BPH
• Present and discuss novel evidence to better understand when and why to start combination treatment
• Reconcile clinical guideline recommendations and clinical practice for the optimal management of patients with moderate to severe BPH at risk of progression
This session is supported by SIU Corporate Sponsor: GlaxoSmithKline
1400-1530
Tips and Tricks in fURS Demo
Location: Lamda/Omega
Chair: Achilles Ploumidis, Greece
Pre-registration is required for this session.
This session will focus more on EndoUrological procedures (RIRS and PCNL) in terms of
Instrumentation, Technique and Tips and Tricks.
Objectives:
- Learn indications of each technique (PCNL and Retrograde Intra-renal Surgery: RIRS)
- Learn instrumentation for each technique (disposable and reusable equipment)
- Learn basics for manipulation of endoscopes and Laser applications
- Learn principles of management of endourological complications
This session is supported by SIU Corporate Sponsor Coloplast.
1545-1715
Symposium
Bridging New Research with Clinical Practice: Hexanic Serenoa Repens for LUTS
Chair: Mauro Gacci, Italy
Location: Aphrodite I-II
Faculty:
Stavros Gravas, Greece
Alexandre de la Taille, France
Objective
Highlight the differences with the other Serenoa Repens extracts of the Hexanic extract of Serenoa repens in terms of composition, anti-inflammatory action and clinical benefits in daily practice.
Plant Extracts
Alexandre de la Taille
Targeting Inflammation: The Role of HESr
Stavros Gravas
HESr for LUTS in Clinical Practice:The Qualiprost Study
Mauro Gacci
This session is supported by Pierre Fabre Medicament.
Sunday, October 20, 2019
1230-1330
Luncheon Symposium
Management Strategies of Urothelial Cancer According to Genomic Alterations
Location: Aphrodite I-II
Chair: Petros Grivas, United States
Faculty:
Aristotelis Bamias, Greece
Michalis Karamouzis, Greece
Description
Discussion on the rapidly evolving molecular landscape in urothelial cancer and therapy implications.
Objectives
- Summarize the current practice in the treatment of advanced urothelial cancer
- Discuss biomarkers and results from clinical trials and reflect on the future of the field
This session is supported by Debiopharm.
